Organization and Summary of Significant Accounting Policies - Additional information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2024	Feb. 20, 2024	Aug. 26, 2022	Dec. 24, 2020
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Investment impairment charges	$ 0	$ 0
Cash and cash equivalents	$ 3,595,101	$ 22,326,356
Common Stock, Shares, Issued	35,876,440	36,025,104
Common Stock Value	$ 3,603	$ 3,588
Short-term investments	0	9,735,930
Research and development	67,800,000
Revenue recognized	2,841,794	6,722,090
Accounts receivable written off	0	0
Accounts receivable, net	1,535,757	417,695
Deferred revenue, Current	1,800,000	0
Deferred offering costs		190,547			$ 15,500,000
Accrual for interest or penalties	0	0
Interest or penalties recognized	$ 0	0
Minimum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Estimated Useful Lives	3 years
Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Estimated Useful Lives	39 years
Subsequent Event
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Additional financing amount			$ 12,500,000
Debt Instrument, Face Amount			10,000,000
Subsequent Event | Senior Notes
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Debt Instrument, Face Amount			$ 2
Private Placement | Subsequent Event
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Common Stock, Shares, Issued				1,785,718
Common Stock Value				$ 2,500,000
IPO | US Treasury Bill Securities
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Proceeds from initial public offering		9,700,000
Common Stock [Member]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
ProceedsFromShelfRegistrationStatement		100,000,000
Wugen License
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Revenue recognized	$ 2,800,000	$ 6,700,000
Accounts receivable, net	$ 1,500,000
Common stock hold by the company						2,174,311
Wugen License | Product | Revenue Benchmark | Product Concentration Risk
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Concentration Risk Percentage1	5.60%